Evidence map›Paper›PMID 38441530›Full record

ArticleAging2024

PR55α-controlled protein phosphatase 2A inhibits p16 expression and blocks cellular senescence induction by γ-irradiation.

Chitra Palanivel, Lepakshe S V Madduri, Ashley L Hein, Christopher B Jenkins, Brendan T Graff, Alison L Camero, Sumin Zhou, Charles A Enke, Michel M Ouellette, Ying Yan

Open access · hybridAbstract read
In one paragraph

Article in Aging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Chitra PalanivelDepartment of Radiation Oncology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Lepakshe S V MadduriDepartment of Radiation Oncology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Ashley L HeinDepartment of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Christopher B JenkinsDepartment of Radiation Oncology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Brendan T GraffDepartment of Radiation Oncology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Alison L CameroDepartment of Radiation Oncology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Sumin ZhouDepartment of Radiation Oncology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Charles A EnkeDepartment of Radiation Oncology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Michel M OuelletteDepartment of Internal Medicine - Gastroenterology and Hepatology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Ying YanDepartment of Radiation Oncology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
University of Nebraska Medical Center · US

Funding

Tracking and Evaluation CoreU54GM115458 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI RIZZO, MATTHEW · 2016 to 2025
$42.8M
Research Pilot Project ProgramP30GM106397 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI JOHNSON, KEITH R · 2013 to 2017
$4.9M
Rac1 GTPase in tumorigenesis and progression of pancreatic cancerR01CA206444 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BATRA, SURINDER K., OUELLETTE, MICHEL M · 2016 to 2020
$1.9M
PR55-alpha controlled PP2A in the regulation of the Hippo/YAP pathwayR01GM143329 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI YAN, YING · 2021 to 2024
$1.3M
NCI NIH HHS R01 CA206444NIGMS NIH HHS P30 GM106397NIGMS NIH HHS R01 GM143329NIGMS NIH HHS U54 GM115458
6 · The paper itself

Abstract

Cellular senescence is a permanent cell cycle arrest that can be triggered by both internal and external genotoxic stressors, such as telomere dysfunction and DNA damage. The execution of senescence is mainly by two pathways, p16/RB and p53/p21, which lead to CDK4/6 inhibition and RB activation to block cell cycle progression. While the regulation of p53/p21 signaling in response to DNA damage and other insults is well-defined, the regulation of the p16/RB pathway in response to various stressors remains poorly understood. Here, we report a novel function of PR55α, a regulatory subunit of PP2A Ser/Thr phosphatase, as a potent inhibitor of p16 expression and senescence induction by ionizing radiation (IR), such as γ-rays. The results show that ectopic PR55α expression in normal pancreatic cells inhibits p16 transcription, increases RB phosphorylation, and blocks IR-induced senescence. Conversely, PR55α-knockdown by shRNA in pancreatic cancer cells elevates p16 transcription, reduces RB phosphorylation, and triggers senescence induction after IR. Furthermore, this PR55α function in the regulation of p16 and senescence is p53-independent because it was unaffected by the mutational status of p53. Moreover, PR55α only affects p16 expression but not p14 (ARF) expression, which is also transcribed from the same

Indexed as

Protein Phosphatase 2Tumor Suppressor Protein p53Cellular SenescenceCyclin-Dependent Kinase Inhibitor p16HumansPhosphoprotein PhosphatasesTumor Suppressor Protein p14ARFCDKN2A protein, humanCyclin-Dependent Kinase Inhibitor p16Phosphoprotein PhosphatasesPPP2R2A protein, humanProtein Phosphatase 2PTPA protein, humanTumor Suppressor Protein p14ARFTumor Suppressor Protein p53CDKN2A locusp14p16p53PP2APR55αRBγ-irradiation

Identifiers

PMID38441530
PMCPMC10968692
OpenAlexW4392401974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.